课题基金 / 基金详情

IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
IGF::OT::IGF 对患有复杂性子宫内膜不典型增生/子宫内膜上皮内瘤变或 1 级子宫内膜癌的女性每日服用依西美坦的试点研究
批准号:
9575740
负责人:
HOWARD BAILEY
金额:
$27.72万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2018-09-14

项目摘要

项目成果

HOWARD BAILEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号:
    10425188
  • 项目类别:
  • 资助金额:
    $70.73万
  • 财政年份:
    2021
  • 负责人:
    HOWARD BAILEY
  • 依托单位:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号:
    10683047
  • 项目类别:
  • 资助金额:
    $10.75万
  • 财政年份:
    2021
  • 负责人:
    HOWARD BAILEY
  • 依托单位:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号:
    10045662
  • 项目类别:
  • 资助金额:
    $82.22万
  • 财政年份:
    2019
  • 负责人:
    HOWARD BAILEY
  • 依托单位:
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
  • 批准号:
    10674471
  • 项目类别:
  • 资助金额:
    $29.66万
  • 财政年份:
    2017
  • 负责人:
    HOWARD BAILEY
  • 依托单位:
海外基金